Effects of Suspension Therapy on Mobility and Balance in Children with Down Syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of Suspension Therapy on the mobility and balance of children aged 3 to 6 years with Down syndrome. It is a randomized controlled trial that will include 26 participants diagnosed with mild to moderate mental retardation. The study will utilize various assessment tools, including the Pediatric Balance Scale and the Four Square Step Test, to measure changes in balance and mobility before and after the intervention. Participants will undergo Suspension Therapy five days a week for one hour each session, with data analyzed using descriptive statistical tools.

Why it matters

Who can join: the full rules

Inclusion Criteria: • Diagnosed children with Down syndrome with mild (IQ: 69-50) to moderate (IQ: 50-35) mental retardation

* Aged between 3 to 6 years
* Both gender
* Able to follow the instructions
* Able to stand and walk

Exclusion Criteria: • Any Cardiovascular disease

* Visual and Hearing impairment
* Orthopedic limitation to exercise such as hip, knee, foot or spinal deformities

Where it's running

• Riphah International University
  Lahore, Punjab Province, Pakistan Recruiting
• Riphah International Universiy
  Lahore, Punjab Province, Pakistan Recruiting

Study contacts

• Principal investigator: Sidra Rukhsar, MS — Riphah International University
• Study coordinator: Imran Amjad Dr, PhD
• Email: Imran.amjad@riphah.edu.pk
• Phone: 9233224390125

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease

  This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.

  Recruiting Phase 3 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Granada, Andalusia and 4 other locations · NCT07234695

• Therapy plan for children with Down syndrome and acute myeloid leukemia in Russia

  This trial will test a standardized four-course chemotherapy program for children (0–18) with AML and Down syndrome in Russia to try to improve survival and reduce treatment side effects.

  Recruiting Phase 3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT07232134

• HEP therapy for motor and sensory development in infants with Down syndrome

  This study tests whether the HEP (Homeostasis‑Enrichment‑Plasticity) therapy helps motor and sensory development in babies aged 4–12 months with Down syndrome.

  Recruiting Medipol University · Istanbul, Beykoz · NCT07163780

• Epi-ON corneal crosslinking with UVA for people with Down syndrome and corneal ectasia

  This trial will try Epi-ON corneal crosslinking (riboflavin drops plus UVA light) to see if it can slow or stop corneal thinning and vision loss in people with Down syndrome who have keratoconus or similar ectatic corneal conditions.

  Recruiting at 12 sites Phase 3 Woolfson Eye Institute · Atlanta, Georgia and 11 other locations · NCT07135167

• Technology to promote healthy lifestyles in young people with intellectual disabilities

  This project will try a smartphone-based program with families and teachers to help children and young adults with intellectual disabilities move more and eat healthier.

  Recruiting University of Seville · Seville, Spain · NCT07101523

• Assessing Inspire therapy for adolescents with Down syndrome and severe sleep apnea

  This study is testing a new sleep therapy for teenagers with Down syndrome and severe sleep apnea to see if it helps them sleep better and improves their quality of life.

  Recruiting Inspire Medical Systems, Inc. · Phoenix, Arizona and 5 other locations · NCT06851338

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.